NITROGLYCERIN-INDUCED CORONARY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS - EVALUATION WITH INVIVO INTRACORONARY ULTRASOUND

被引:65
作者
PINTO, FJ [1 ]
STGOAR, FG [1 ]
FISCHELL, TA [1 ]
STADIUS, ML [1 ]
VALANTINE, HA [1 ]
ALDERMAN, EL [1 ]
POPP, RL [1 ]
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DIV CARDIOVASC MED,STANFORD,CA 94305
关键词
INTRAVASCULAR IMAGING; ECHOCARDIOGRAPHY; HEART TRANSPLANTATION; CORONARY ARTERY DISEASE;
D O I
10.1161/01.CIR.85.1.69
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Coronary artery vasomotion is altered after cardiac transplantation. The impact of accelerated transplant coronary atherosclerosis and myocardial rejection on vasomotion is not well understood. Intravascular ultrasound is a new imaging method with the ability to study real-time changes in coronary artery dimensions. Methods and Results. Epicardial coronary artery response to nitroglycerin was studied in 32 cardiac transplant recipients (age, 47 +/- 11 years) 3 weeks to 10 years after transplantation with intracoronary ultrasound. Cross-sectional luminal area and diameter were measured at a fixed position in the left anterior descending artery immediately before and every 30 seconds for 5 minutes after 0.4 mg of sublingual nitroglycerin. Cross-sectional area increased from a baseline of 13.1 +/- 3.9 mm2 to 15.8 +/- 3.9 mm2 at maximal vasodilation; luminal diameter increased from 4.0 +/- 0.6 mm to 4.5 +/- 0.6 mm. This increase reached statistical significance (p < 0.001) at 1.5 minutes after administration of nitroglycerin; mean maximum increase occurred at 4.5 minutes (24% for cross-sectional area and 11% for luminal diameter). Patients with biopsy-proven mild or moderate concurrent rejection had a significantly blunted vasodilatory response versus the nonrejection group (9% versus 27% for cross-sectional area, p < 0.04), although a vasodilatory effect was still present. Nitroglycerin response was well preserved in patients up to 10 years after transplantation; however, there was a trend toward a decreased response in patients studied immediately after transplantation (21% versus 29%, p = 0.37). Coronary intimal thickness, as measured by ultrasound, had no impact on the vasodilatory response (R = 0.23, p = 0.34). Conclusions. Vasodilatory response to nitroglycerin in cardiac transplant recipients is attenuated during episodes of cardiac rejection. This response is preserved in long-term survivors and is independent of the degree of intimal thickening. Intravascular ultrasound provides a new method to document real-time epicardial coronary vasomotion.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 45 条
  • [1] BIEBER CP, 1981, TRANSPLANT P, V13, P207
  • [2] BILLINGHAM ME, 1989, TRANSPLANT P, V21, P3665
  • [3] BILLINGHAM ME, 1981, HEART TRANSPLANT, V1, P25
  • [4] THE MECHANISMS OF NITROGLYCERIN ACTION - STENOSIS VASODILATATION AS A MAJOR COMPONENT OF THE DRUG RESPONSE
    BROWN, BG
    BOLSON, E
    PETERSEN, RB
    PIERCE, CD
    DODGE, HT
    [J]. CIRCULATION, 1981, 64 (06) : 1089 - 1097
  • [5] DYNAMIC MECHANISMS IN HUMAN CORONARY STENOSIS
    BROWN, BG
    BOLSON, EL
    DODGE, HT
    [J]. CIRCULATION, 1984, 70 (06) : 917 - 922
  • [6] DUMONT L, 1990, J HEART TRANSPLANT, V9, P213
  • [7] MAGNITUDE OF DILATATION OF LARGE AND SMALL CORONARY-ARTERIES BY NITROGLYCERIN
    FELDMAN, RL
    PEPINE, CJ
    CONTI, CR
    [J]. CIRCULATION, 1981, 64 (02) : 324 - 333
  • [8] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01
    FISHER, B
    WOLMARK, N
    ROCKETTE, H
    REDMOND, C
    DEUTSCH, M
    WICKERHAM, DL
    FISHER, ER
    CAPLAN, R
    JONES, J
    LERNER, H
    GORDON, P
    FELDMAN, M
    CRUZ, A
    LEGAULTPOISSON, S
    WEXLER, M
    LAWRENCE, W
    ROBIDOUX, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01): : 21 - 29
  • [9] FITZGERALD PJ, 1991, J AM COLL CARDIOL S, V17, pA217
  • [10] THE CAUSAL ROLE OF PAF AND LEUKOTRIENES IN ACUTE CARDIAC ALLOGRAFT-REJECTION IN RATS
    FOEGH, ML
    KHIRABADI, BS
    ROWLES, JR
    BRAQUET, P
    RAMWELL, PW
    [J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 : 127 - 132